BIOACTIVE PEPTIDE MARKET ANALYSIS

Market Challenges And Opportunities

Global Bioactive Peptide Market: Restraint

Increasing number of bioactive peptides alternatives is one of the major factors, which is expected to hamper growth of the global bioactive peptides market over the forecast period, Such as fungi, edible insects, marine macro algae and vegetable proteins.

Other major factor hindering the market growth is lack of documented evidence of safety, lack of complete knowledge regarding the mechanism and functions of bioactive peptides.

Global Bioactive Peptide Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

Increasing research and development by key players during the pandemic for the treatment of Covid-19 patients is expected to boost the bioactive peptide market growth. For instance, in April 2020, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that it had signed, together with the solnatide consortium, the Grant Agreement with the European Commission to accelerate the process of making APEPTICO’s proprietary investigational medicinal product (IMP), Solnatide available for medical treatment of patients severely affected by the novel coronavirus 2019 (SARS-CoV-2) disease, COVID-19.

Thus, impact of the Coronavirus (COVID-19) pandemic had positive impact on the global bioactive peptide market during the pandemic.